| Valuation method | Value, € | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 1170.55 | 8768 |
| Intrinsic value (DCF) | 1.40 | -89 |
| Graham-Dodd Method | n/a | |
| Graham Formula | 231.36 | 1653 |
Mexedia Società Per Azioni S.B. (ALMEX.PA) is an Italy-based technology company specializing in telecommunications and business services. Formerly known as Airtime Partecipazioni S.p.A., the company rebranded in May 2022 to reflect its focus on automating and enhancing communication technologies for sales, marketing, and customer care. Operating in the financial services sector under asset management, Mexedia provides innovative solutions to streamline interactions between brands and customers. Headquartered in Rome, the company leverages technology to optimize business processes, though it faces financial challenges with recent net losses. Listed on Euronext Paris, Mexedia aims to carve a niche in the competitive European tech and financial services landscape.
Mexedia Società Per Azioni S.B. presents a high-risk investment opportunity due to its recent financial performance, including a net loss of €20.01 million in the latest fiscal period and negative EPS of -€4.61. The company operates in the competitive telecommunications and business services sector, with a market cap of approximately €28.46 million. While its beta of -0.43 suggests low correlation with broader market movements, the lack of positive operating cash flow and profitability raises concerns. Investors should closely monitor the company's ability to pivot toward sustainable growth and profitability in the evolving tech and financial services industry.
Mexedia operates at the intersection of technology and financial services, offering communication automation solutions for businesses. Its competitive positioning is challenged by larger, more established players in both the telecommunications and asset management sectors. The company's niche focus on automating customer interactions provides differentiation, but its financial instability (evidenced by recent losses) limits its ability to scale or invest in R&D. Unlike competitors with diversified revenue streams, Mexedia's reliance on a narrow service offering increases vulnerability to market shifts. Its rebranding in 2022 suggests a strategic pivot, but execution risks remain high given the capital-intensive nature of the industry. The lack of reported operating cash flow or capital expenditures further obscures its capacity to compete effectively.